| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/16/2001 | EP0759944B1 Target cell binding chimaeric peptides |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2400802A1 Compositions and methods for screening therapeutic agents |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400488A1 Methods for the prevention and treatment of infections using anti-c3b(i) antibodies |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2399969A1 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399860A1 Udp-galactose: .beta.-d-galactose-r 4-.alpha.-d-galactosyltransferase, .alpha.4gal-t1 |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399349A1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2392450A1 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | CA2368681A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/15/2001 | CN1308676A Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308540A Anti-diarrheal and method for using the same |
| 08/15/2001 | CN1308087A Human testis specific protein gene coding protein |
| 08/15/2001 | CA2332132A1 Assays for measurement of type ii collagen fragments in urine |
| 08/14/2001 | US6274789 Rice gene resistant to blast disease |
| 08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
| 08/14/2001 | US6274711 Proteins and mimetics which function in regulating, controlling physiology, development, and differentiation of mammalian immune cells including hemopoietic type; cytotoxic t lymphocyte activated or associated antigen (ctla) |
| 08/14/2001 | US6274706 Intron/exon of the human and mouse beta 3-adrenergic receptor genes |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274376 An isolated polynucleotide encoding an atp depentent protease; therapy and diagnosis of respiratory diseases, central nervous systems disorders, septic arthritis, skin disorders and toxic shock syndrome |
| 08/14/2001 | US6274366 A dna expression construct transformed in yeast cells; treatment of angiogenesis and tissue remodeling |
| 08/14/2001 | US6274365 A carrier compound containing an active recombinant furin enzyme; gene therapy; treatment of cancer |
| 08/14/2001 | US6274362 RGS-containing molecules and uses thereof |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |
| 08/14/2001 | US6274359 Amino acid sequence; for recombinant production of enzyme and production of 1-alpha, 25-dihydroxyvitamin d3; prevention, diagnosis and treatment of osteoporosis |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274334 Hybridoma cell line; detection and quantitative determination of trace amounts in samples such as animal tissue, body fluids and feed material |
| 08/14/2001 | US6274332 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 08/14/2001 | US6274327 Genereting antibody which preferentially binds enzymatic polypeptide; administer immunogen to animal and isolate antibody from animal |
| 08/14/2001 | US6274324 Specific binding reagent comprising a variable domain protein linked to a support or tracer |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274318 Detecting modulators of enzyme activity; incubate enzymatic sample and inhibitor, detect reduce activity from enzyme |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274144 Method for generating antibodies to saccharide fragments |
| 08/14/2001 | US6274143 Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10 |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/10/2001 | CA2298737A1 2167334tgf-.beta. antagonists to inhibit tumor cell formation or progression |
| 08/09/2001 | WO2001057535A2 Analytical method to evaluate animal models of neurofibrillary degeneration |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057233A2 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057224A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 08/09/2001 | WO2001057209A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof |
| 08/09/2001 | WO2001057199A1 Antibody for detecting mycoplasma pneumoniae |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057188A2 Novel nucleic acids and polypeptides |
| 08/09/2001 | WO2001057182A2 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | WO2001057175A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057089A1 Antibody for detecting chlamydia pneumoniae |
| 08/09/2001 | WO2001057088A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
| 08/09/2001 | WO2001057085A2 G-protein coupled receptors |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001056606A1 Remedies for ophthalmic diseases |
| 08/09/2001 | WO2001056605A1 Porin b (porb) as a threrapeutic target for prevention and treatment of infection by chlamydia |
| 08/09/2001 | WO2001056604A1 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies |
| 08/09/2001 | WO2001056603A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001004316A3 Antigenic meningococcal peptides |
| 08/09/2001 | WO2000074729A3 Alpha or beta emitters to fragments in radioimmunotherapy |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000069895A3 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 08/09/2001 | WO2000063351A3 Carbohydrate-modifying enzymes |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | US20010012836 Determining the presence or absence of a mutation in the nucleotide sequence or absence of a mutation in nucleotide sequence encoding the specific polypeptides in the genome of the subject and analyzing for presence of polypeptide |
| 08/09/2001 | US20010012831 Calcium-binding protein |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012515 Isolated polypeptide |
| 08/09/2001 | US20010012514 Neutralizing, removal antibodies |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399681A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399672A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |